CeGat Genetic Disease Prevention Test
Personalised healthcare for early detection of your risk of genetic disease
1 in 7 people carry genetic variants that can cause cancer and other medical conditions. There are a range of preventive measures that can often be taken – and early diagnosis and treatment is usually more effective. The CeGat Genetic Disease Prevention Test offers the early detection of genetic risk factors to support early intervention.
What is it and how does it work?
After an initial genetic consultation by a qualified specialist, a simple blood test is taken and sent to our partner lab for analysis. CeGaT then sequences all genes in the screening panel using Next- Generation Sequencing. Analysis and interpretation of the sequencing data is followed by preparation of a detailed medical report. Finally a specialist will discuss the findings and recommendations from the genetic test.
CeGaT is a global provider of genetic analyses for a wide range of medical, research, and pharmaceutical applications.
Founded 2009 in Tübingen, Germany, the company combines state-of-the-art sequencing technology with senior medical expertise. For researchers and pharmaceutical companies, CeGaT offers a broad portfolio of sequencing services and tumour analyses. CeGaT’s laboratory is accredited to CAP/CLIA, DIN EN ISO 15189, DIN EN ISO/IEC 17025 and meets the highest international standards.